In a letter to Nature, two women working in life science organizations – one in South Africa and one in the US – made a brief but striking case for greater pharmaceutical production capabilities in low-and-middle-income (LMIC) countries. They highlighted new technologies that would support small-scale manufacturing units, arguing that Africa’s “leapfrog” over complex wired infrastructure to cellphone-based communications proves that LMIC countries need not mirror pathways to development once taken in the Global North.
To dig a little deeper, we spoke with the two women in question – Rachel Chikwamba (Group Executive, Advanced Chemistry and Life Sciences, Council for Scientific and Industrial Research) and Kerry Love (Founder and CEO, Sunflower Therapeutics PBC).
Issued by The Medicine Maker
Contact Person: